The Clofazimine Challenge: Management of Refractory Mycobacterium abscessus in Pediatric Patients with Cystic Fibrosis
This activity will impact the interprofessional healthcare team by shedding light on the potential use of clofazimine for the treatment of a complex pulmonary infection caused by an intrinsically multi-drug resistant bacteria (Mycobacterium abscessus).
Target Audience
Pharmacist
Learning Objectives
Discuss Mycobacterium abscessus-associated pulmonary disease in pediatric cystic fibrosis patients
Identify guideline-based therapy recommended to treat Mycobacterium abscessus pulmonary disease
Discuss the pharmacology and clinical concerns associated with the use of clofazimine
Formulate a plan for treatment of refractory Mycobacterium abscessus pulmonary disease including clofazimine
This activity will impact the interprofessional healthcare team by shedding light on the potential use of clofazimine for the treatment of a complex pulmonary infection caused by an intrinsically multi-drug resistant bacteria (Mycobacterium abscessus).
Matt Whiteman, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 1.00 Attendance